More Stories

Cardiology Business August 10, 2026

iRhythm Expands MCT Footprint with VitalConnect Acquisition August 10, 2026

iRhythm, best known for its Zio cardiac monitoring wearables, is moving to expand well beyond its 14-day-patch roots by acquiring wearable biosensor company VitalConnect for $287.5M.

Cardiology Pharmaceuticals August 6, 2026

ZEUS Tells Us Inflammation Might Not Be the Answer August 6, 2026

Cardiovascular inflammation has been the talk of the town in cardiology, and while Novo Nordisk was wise to pursue treating it, results from the ZEUS trial have led to a thunderous debate on whether or not it ever played a role in ASCVD.

Cardiology August 3, 2026

How to Make Cardiologists Love Academia Again August 3, 2026

Cardiology is one of the most data-driven medical specialties a physician can pursue. So why is the source of that data – cardiac academia – declining in both workforce and prestige?

Cardiology Pharmaceuticals July 31, 2026

Another Look at Attruby Reveals Bolstered Benefits July 31, 2026

As the ATTR-CM market gets more crowded, medications will have to prove their place, and a sub-analysis of the ATTRibute-CM trial shows BridgeBio’s Attruby (acoramidis) has the efficacy to remain competitive.

Structural Heart July 30, 2026

Knowing When to Intervene in Mitral Regurgitation July 30, 2026

A common question in structural heart cardiology is “when do we know to intervene?” and recently released 25-year mitral regurgitation data might just have given us an answer.

Cardiology July 27, 2026

The Career Perceptions of Heart Failure Cardiology July 27, 2026

Picture this – you graduate medical school (not easy), you do a three-year internal medicine residency, then a three-year general cardiology fellowship, and another year of fellowship, but you’re paid less than your peers in other subspecialties – congrats, you’re an advanced heart failure cardiologist (AHFTC).

Get twice-weekly insights on the biggest stories shaping cardiology.